ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma.

Elizabeth R Gerstner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.